Search
Search
Search results 12
AmoyDx Lung Cancer PCR Panel accepted into LC-SCRUM as Screening Test for Pharma Clinical Trials in Japan
Xiamen, China — September 30, 2019 -- Amoy Diagnostics Co., Ltd (AmoyDx, SZSE:300685), a leading company in companion diagnostics for precision oncology, today announced that the AmoyDx Lung Cancer PCR Panel has been accepted as first-line screening for p
News & Events
AmoyDx and PREMIA Jointly Announce Strategic Partnership to Establish Asia Cancer Clinical Genomic Network
Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, has entered into a strategic partnership agreement with Amoy Diagnostics Co., Ltd. and with PREMIA Holdings (HK) Ltd.
News & Events
Sanomics Limited and Amoy Diagnostics Partner to Deliver Multi-Gene Tests in Hong Kong and Macau
Xiamen, 28 January 2019 – Amoy Diagnostics Co., LTD., a leading company focusing on molecular diagnostics for precision oncology, and Sanomics Limited, a pioneering company in providing genomics tests in
News & Events
2018 AmoyDx Distributors Annual Meeting successfully held in Shanghai
November 11, 2018 (Shanghai, China) AmoyDx Distributors Annual Meeting 2018 was held in Shanghai on November 8, 2018. 34 delegates from 19 countries gathered together to get the latest market
News & Events
Amoy Diagnostics achieved China NMPA Approval of Multi-Genes Mutations Detection Kit
Amoy Diagnostics Co., Ltd. (AmoyDx, SHE:300685) announced that NMPA(National Medical Products Administration)approved its Multi-Genes Mutations Detection Kit on Aug 24, 2018.
News & Events
Pan Lung Cancer PCR Panel
PRODUCTS
Multi-Gene Mutations Detection Kit
PRODUCTS
Multi-Gene-L1-01 Comparison of EML4-ALK fusion gene positive rate in different detection methods and samples of non–small cell lung cancer
DOWNLOAD
Multi-Gene-L1-01 Comparison of EML4-ALK fusion gene positive rate in different detection methods and samples of non–small cell lung cancer
DOWNLOAD
MSDS-multi-gene panel-202001
DOWNLOAD
AmoyDx® Multi-Gene Mutations Detection Kit-P2.7-6T
DOWNLOAD
Multi-Gene-2018 AMP-A novel and accurate real-time PCR approach for simultaneous detection of multiple driver gene mutations in non-small cell lung cancer
DOWNLOAD
no more...
AmoyDx Lung Cancer PCR Panel accepted into LC-SCRUM as Screening Test for Pharma Clinical Trials in Japan
Xiamen, China — September 30, 2019 -- Amoy Diagnostics Co., Ltd (AmoyDx, SZSE:300685), a leading company in companion diagnostics for precision oncology, today announced that the AmoyDx Lung Cancer PCR Panel has been accepted as first-line screening for p
News & Events
AmoyDx and PREMIA Jointly Announce Strategic Partnership to Establish Asia Cancer Clinical Genomic Network
Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, has entered into a strategic partnership agreement with Amoy Diagnostics Co., Ltd. and with PREMIA Holdings (HK) Ltd.
News & Events
Sanomics Limited and Amoy Diagnostics Partner to Deliver Multi-Gene Tests in Hong Kong and Macau
Xiamen, 28 January 2019 – Amoy Diagnostics Co., LTD., a leading company focusing on molecular diagnostics for precision oncology, and Sanomics Limited, a pioneering company in providing genomics tests in
News & Events
2018 AmoyDx Distributors Annual Meeting successfully held in Shanghai
November 11, 2018 (Shanghai, China) AmoyDx Distributors Annual Meeting 2018 was held in Shanghai on November 8, 2018. 34 delegates from 19 countries gathered together to get the latest market
News & Events
Amoy Diagnostics achieved China NMPA Approval of Multi-Genes Mutations Detection Kit
Amoy Diagnostics Co., Ltd. (AmoyDx, SHE:300685) announced that NMPA(National Medical Products Administration)approved its Multi-Genes Mutations Detection Kit on Aug 24, 2018.
News & Events
no more...
Inquiry
* Required information
Manage your account info
Change your password